Premium
Globalization of the Pharmaceutical Industry: The Physician's Role in Optimizing Drug Use
Author(s) -
Young Michael D.
Publication year - 1990
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/j.1552-4604.1990.tb03583.x
Subject(s) - globalization , pharmaceutical industry , competition (biology) , drug prices , dissemination , unification , drug industry , business , economic competition , marketing , drug , public relations , medicine , public economics , pharmacology , international trade , economics , political science , engineering ethics , engineering , market economy , computer science , law , ecology , european union , biology , programming language
In this new era of globalization, the physician must consider cultural differences in choosing methods of disseminating information so that practitioners in diverse settings may optimize drug usage. In addition, increasing competition, stimulated by the imminent unification of the European market in 1992, demands that the industry physician be concerned with developing possible new indications and cost‐effective applications. These factors will enhance roles for the medical affairs physician in the pharmaceutical industry.